Cargando…
Malignant hyperthermia: a review
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, and rarely, in humans, to stressors...
Autores principales: | Rosenberg, Henry, Pollock, Neil, Schiemann, Anja, Bulger, Terasa, Stowell, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524368/ https://www.ncbi.nlm.nih.gov/pubmed/26238698 http://dx.doi.org/10.1186/s13023-015-0310-1 |
Ejemplares similares
-
Functional analysis of RYR1 variants linked to malignant hyperthermia
por: Stephens, Jeremy, et al.
Publicado: (2016) -
Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia
por: Parker, Remai, et al.
Publicado: (2017) -
Malignant hyperthermia
por: Rosenberg, Henry, et al.
Publicado: (2007) -
Targeted exon capture and NGS to investigate an undefined myopathy reveal RYR1 variants
por: Stowell, Kathryn, et al.
Publicado: (2014) -
Variant Curation Expert Panel Recommendations for RYR1 Pathogenicity Classifications in Malignant Hyperthermia Susceptibility
por: Johnston, Jennifer J., et al.
Publicado: (2021)